SALICYLATE POISONING - 2-DIMENSIONAL J-RESOLVED NMR URINALYSIS

被引:10
作者
MASCHKE, S
AZAROUAL, N
IMBENOTTE, M
VERMEERSCH, G
LECLERC, F
LHERMITTE, M
机构
[1] FAC SCI PHARMACEUT & BIOL LILLE,TOXICOL LAB,F-59006 LILLE,FRANCE
[2] CTR HOSP REG & UNIV LILLE,HOP CALMETTE,SERV REANIMAT PEDIAT A,F-59037 LILLE,FRANCE
[3] FAC SCI PHARMACEUT BIOL LILLE,PHYS LAB,CNRS,URA 351,F-59006 LILLE,FRANCE
[4] UNIV LILLE 2,APPLICAT RMN LAB,F-59006 LILLE,FRANCE
关键词
D O I
10.1002/nbm.1940080105
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Identification of a case of acute salicylate intoxication using 300 MHz H-1 NMR spectroscopy of a urine sample is reported. It has been achieved by using a combination of a one-dimensional experiment with water presaturation and a two-dimensional homonuclear J-resolved experiment. By these means, lysine and the three major metabolites of acetylsalicylic acid have been assigned in the crude urine, The results are compared with those obtained at 600 MHz and with classical biochemical methods, The use of this method for routine diagnosis in biological analysis is discussed.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 23 条
[1]   PERCUTANEOUS SALICYLATE POISONING [J].
ANDERSON, JAR ;
EAD, RD .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1979, 4 (03) :349-351
[2]  
BALES JR, 1984, CLIN CHEM, V30, P426
[3]   SALICYLATE METABOLITE KINETICS AFTER SEVERAL SALICYLATES [J].
BOCHNER, F ;
GRAHAM, GG ;
CHAM, BE ;
IMHOFF, DM ;
HAAVISTO, TM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :266-275
[4]   ANALYSIS OF BIOLOGICAL-FLUIDS USING 600 MHZ PROTON NMR-SPECTROSCOPY - APPLICATION OF HOMONUCLEAR 2-DIMENSIONAL J-RESOLVED SPECTROSCOPY TO URINE AND BLOOD-PLASMA FOR SPECTRAL SIMPLIFICATION AND ASSIGNMENT [J].
FOXALL, PJD ;
PARKINSON, JA ;
SADLER, IH ;
LINDON, JC ;
NICHOLSON, JK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (01) :21-31
[5]   750 MHZ 1H-NMR SPECTROSCOPY OF HUMAN BLOOD-PLASMA [J].
FOXALL, PJD ;
SPRAUL, M ;
FARRANT, RD ;
LINDON, LC ;
NEILD, GH ;
NICHOLSON, JK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (4-5) :267-276
[6]  
GEORGE E, 1992, NEW ENGL J MED, V326, P1272
[7]  
GOSSEL TA, 1990, PRINCIPLES CLIN TOXI, P242
[8]  
GRAVES P, 1954, BIOCHEM J, V5, P301
[9]  
HOLMES E, 1992, MOL PHARMACOL, V42, P922
[10]  
ILES RA, 1986, CLIN CHIM ACTA, V173, P173